Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent Glioblastoma

Name: Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent Glioblastoma
License: Public Domain

OX2 Therapeutics

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

glioblastoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 300269
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.